An overview on COVID-19: reality and expectation

Bulletin of the National Research Centre
Manal A Hamed

Abstract

Recently, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), commonly known as coronavirus disease-2019 (COVID-19) has rapidly spread across China and around the world. By the declaration of WHO, COVID-19 outbreak considered as a public health problem of international concern. The aim of this study is to provide a comprehensive view on COVID-19 and the future expectations to control virus progression. Patients with liver disease, diabetes, high blood pressure, and obesity are more susceptible to the incidence of COVID-19 infection. So, there is a rapid need for disease diagnosis, vaccine development, and drug discovery to detect, prevent, and treat this sudden and lethal virus. Real-time polymerase chain reaction (RT-PCR) is considered as a rapid, accurate, and specific tool for disease diagnosis. Under this emergency situation that the world facing against COVID-19, there are about 15 potential vaccine candidates tested globally based on messenger RNA, DNA-based, nanoparticle, synthetic, and modified virus-like particle. Certain drugs that are clinically approved for other diseases were tested against COVID-19 as chloroquine, hydroxychloroquine, ivermectin, favipiravir, ribavirin, and remdesivir. Convalescent plasma...Continue Reading

References

May 16, 2003·The New England Journal of Medicine·Kathryn V Holmes
Nov 1, 2003·The Lancet Infectious Diseases·Andrea SavarinoRoberto Cauda
Dec 13, 2003·The Journal of Biological Chemistry·Swee Kee WongMichael Farzan
Mar 5, 2004·The Journal of Biological Chemistry·Brian TripetRobert S Hodges
May 27, 2004·Physiological Genomics·Denong Wang, Jiahai Lu
Nov 9, 2004·Biochemical and Biophysical Research Communications·Yuxian HeShibo Jiang
Dec 4, 2004·Nature Medicine·J S M PeirisK Y Yuen
Dec 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y ChengG Cheng
Jun 9, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·J K YangJ C N Chan
Oct 5, 2007·The New England Journal of Medicine·Boping ZhouYi Guan
May 16, 2008·Journal of Ethnopharmacology·Kit-Man LauKwok-Pui Fung
Jun 10, 2009·Antimicrobial Agents and Chemotherapy·Els KeyaertsPiet Maes
Jan 21, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ivan Fn HungKwok-Yung Yuen
Feb 22, 2012·Biotechnology Letters·Thi Thanh Hanh NguyenDoman Kim
Oct 19, 2012·The New England Journal of Medicine·Ali M ZakiRon A M Fouchier
Sep 3, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hisham MomattinJaffar A Al-Tawfiq
Nov 7, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Yuan GaoYun Qi
Aug 12, 2014·Antiviral Research·Jean-François Rossignol
Apr 24, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen S KraftUNKNOWN Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit
Jun 18, 2015·Frontiers in Microbiology·Wahyu N WulanReena Ghildyal
Jun 25, 2015·Biomedical Research·Saori TakahashiToshihiro Sugiyama
Apr 21, 2016·Journal of Infection and Public Health·Jean-François Rossignol
Aug 5, 2017·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Yousuke FurutaTakaaki Nakamura
Oct 6, 2017·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Massimo LeggioAndrea Mazza
Sep 27, 2018·The Journal of Clinical Endocrinology and Metabolism·Ahmed IqbalIan Sabroe
Aug 23, 2019·Chemical Biology & Drug Design·Seri JoMi-Sun Kim
Nov 15, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Seri JoMi-Sun Kim
Nov 30, 2019·International Journal of Environmental Research and Public Health·Abayomi Samuel Oyekale
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Jan 30, 2020·Viruses·Lisa E Gralinski, Vineet D Menachery
Jan 30, 2020·The New England Journal of Medicine·Qun LiZijian Feng
Jan 31, 2020·Bioscience Trends·Hongzhou Lu
Feb 1, 2020·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·D ParaskevisS Tsiodras

❮ Previous
Next ❯

Citations

Jan 23, 2021·Clinical Journal of Oncology Nursing·Ellen Carr
Dec 18, 2020·BMJ Case Reports·Peter M HaddadYousaf Iqbal
Jun 4, 2021·International Journal of General Medicine·Hui JiaShuyue Xia
Jun 9, 2021·Disaster Medicine and Public Health Preparedness·Kiran RafiqZafar Saied Saify

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
glycosylation

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

Drug Development Research
Fatemeh BabaeiHossein Hosseinzadeh
Cardiovascular Drugs and Therapy
Azita Hajhossein TalasazBabak Geraiely
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Tarek Mohamed Abd El-Aziz, James D Stockand
© 2022 Meta ULC. All rights reserved